Press Release: Sanofi and GSK's next-generation COVID-19 booster vaccine VidPrevtyn® Beta approved by the European CommissionGlobeNewsWire • 11/10/22
GSK slide wipes £2.5bn off its market value, but for one broker this puts the stock in bargain basement territoryProactive Investors • 11/07/22
GSK to submit urinary infection treatment for approval after trial successProactive Investors • 11/03/22
GSK Surges As Shingles Vaccine Drives Commanding Third-Quarter BeatInvestors Business Daily • 11/02/22
GSK results top City forecasts, UBS sees consensus EPS forecasts rising 3%Proactive Investors • 11/02/22
GSK lifts guidance again as bumper third quarter results top City forecastsProactive Investors • 11/02/22
Wednesday's Agenda- Next to iron out latest figures, GSK expecting disappointing resultsProactive Investors • 11/01/22